PathologyWatch inks $25m Series B

PathologyWatch, a digital lab and pathology platform for dermatologists, has raised $25 million in Series B financing.

PathologyWatch, a digital lab and pathology platform for dermatologists, has raised $25 million in Series B financing. The investors include Ceros Capital Markets, Rock Creek Capital, SpringTide, Spark Growth Ventures, Blueprint Health and Blackbrook Management Group.

Source: Press Release